Biopsies are performed in several autoimmune diseases to diagnose or classify them Tolerance and information of the patients have been poorly evlauated our objective is to evaluate tolerance and information of the patients after the biopsies for salivary gland, temporal arteries and neuromuscular.
patinets that benefited of arterial temporal biospy or salivary gland biospy or muscuar biopsy or neuro muscular biospy for his auto -mmune disease will be included and fill standardized questionnaires concerning tolerance, information and side effect at inclusion , day 7 and day 30 after the biopsy data will be analysed to evaluate information, tolerance and risk factor af side effect
Study Type
OBSERVATIONAL
Enrollment
505
CHU d'ANGERS
Angers, France
CHU de Bordeaux
Bordeaux, France
CHRU de Brest
Brest, France
CHU de LILLE
Lille, France
tolerance of each type of biopsy
tolerance based on a standardized patient 's questionnaire
Time frame: tolerance at day 7 after the biospy was performed
tolerance of each type of biopsy 30 days after
tolerance based on a standardized patient 's questionnaire
Time frame: tolerance at day 30 and at inclusion after the biospy was performed
evaluation of the qualitiy of patient's information at inclusion
standardized questionnaire at inclusion
Time frame: questionnaire at inclusion
risk factor of sied effect of each biospy
standardized questionnaire
Time frame: standardized questionnaire at inclusion, day 7 and 30
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CHU de Marseille
Marseille, France
Hôpital de la Salpétrière
Paris, France
CH de Quimper
Quimper, France
CHU de Tours
Tours, France